Konstantinos G Moulakakis1, Spyridon N Mylonas1, Ilias Dalainas1, John Kakisis1, Thomas Kotsis1, Christos D Liapis1. 1. 1 Department of Vascular Surgery, Athens University Medical School, Attikon University Hospital, Athens, Greece ; 2 The Collaborative Research Group, Macquarie University, Sydney, Australia ; 3 Vascular Unit, 2nd Clinic of Surgery, Aretaieion Hospital, Medical School, University of Athens, Athens, Greece.
Abstract
BACKGROUND: The management of acute type B dissection represents a clinical challenge. We undertook a systematic review of the available literature regarding medical, surgical and endovascular treatments of acute type B aortic dissection and combined the eligible studies into a meta-analysis. METHODS: An extensive electronic health database search was performed on all articles published from January 2006 up to November 2013 describing the management of acute type B aortic dissection. Studies including less than 15 patients were excluded. RESULTS: ACUTE COMPLICATED TYPE B DISSECTION: overall, 2,531 patients were treated with endovascular repair (TEVAR) and the pooled rate for 30-day/in-hospital mortality was 7.3%. The pooled estimates for cerebrovascular events, spinal cord ischemia (SCI) and total neurologic events were 3.9%, 3.1% and 7.3%, respectively. A total of 1,276 patients underwent open surgical repair and the pooled rate for 30-day/in-hospital mortality was 19.0%. The pooled rate for cerebrovascular events was 6.8%, for SCI 3.3% and for total neurologic complications 9.8%. Acute uncomplicated type B dissection: outcome of 2,347 patients who underwent conservative medical management were analyzed. The pooled 30-day/in-hospital mortality rate was 2.4%. The pooled rate for cerebrovascular events was 1%, for SCI 0.8% and for overall neurologic complications 2%. CONCLUSIONS: Endovascular repair provides a superior 30-day/in-hospital survival for acute complicated type B aortic dissection compared to surgical aortic reconstruction. However, open repair still has a significant role as endovascular repair is not applicable in all patients and there remains concerns regarding the durability of this technique. TEVAR seems to have a more favorable outcome regarding aortic remodeling and the aortic-specific survival rate when compared with medical therapy alone. Randomized controlled trials focusing on the prognostic factors of early and late complications in uncomplicated type B dissections are needed.
BACKGROUND: The management of acute type B dissection represents a clinical challenge. We undertook a systematic review of the available literature regarding medical, surgical and endovascular treatments of acute type B aortic dissection and combined the eligible studies into a meta-analysis. METHODS: An extensive electronic health database search was performed on all articles published from January 2006 up to November 2013 describing the management of acute type B aortic dissection. Studies including less than 15 patients were excluded. RESULTS: ACUTE COMPLICATED TYPE B DISSECTION: overall, 2,531 patients were treated with endovascular repair (TEVAR) and the pooled rate for 30-day/in-hospital mortality was 7.3%. The pooled estimates for cerebrovascular events, spinal cord ischemia (SCI) and total neurologic events were 3.9%, 3.1% and 7.3%, respectively. A total of 1,276 patients underwent open surgical repair and the pooled rate for 30-day/in-hospital mortality was 19.0%. The pooled rate for cerebrovascular events was 6.8%, for SCI 3.3% and for total neurologic complications 9.8%. Acute uncomplicated type B dissection: outcome of 2,347 patients who underwent conservative medical management were analyzed. The pooled 30-day/in-hospital mortality rate was 2.4%. The pooled rate for cerebrovascular events was 1%, for SCI 0.8% and for overall neurologic complications 2%. CONCLUSIONS: Endovascular repair provides a superior 30-day/in-hospital survival for acute complicated type B aortic dissection compared to surgical aortic reconstruction. However, open repair still has a significant role as endovascular repair is not applicable in all patients and there remains concerns regarding the durability of this technique. TEVAR seems to have a more favorable outcome regarding aortic remodeling and the aortic-specific survival rate when compared with medical therapy alone. Randomized controlled trials focusing on the prognostic factors of early and late complications in uncomplicated type B dissections are needed.
Entities:
Keywords:
Type B aortic dissection; acute; endovascular; medical treatment
Authors: Michael A Coady; John S Ikonomidis; Albert T Cheung; Alan H Matsumoto; Michael D Dake; Elliot L Chaikof; Richard P Cambria; Christina T Mora-Mangano; Thoralf M Sundt; Frank W Sellke Journal: Circulation Date: 2010-06-07 Impact factor: 29.690
Authors: Santi Trimarchi; Christoph A Nienaber; Vincenzo Rampoldi; Truls Myrmel; Toru Suzuki; Eduardo Bossone; Valerio Tolva; Michael G Deeb; Gilbert R Upchurch; Jeanna V Cooper; Jianming Fang; Eric M Isselbacher; Thoralf M Sundt; Kim A Eagle Journal: Circulation Date: 2006-07-04 Impact factor: 29.690
Authors: Anthony L Estrera; Charles C Miller; Jennifer Goodrick; Eyal E Porat; Paul E Achouh; Jayesh Dhareshwar; Riad Meada; Ali Azizzadeh; Hazim J Safi Journal: Ann Thorac Surg Date: 2007-02 Impact factor: 4.330
Authors: Ahmad Zeeshan; Edward Y Woo; Joseph E Bavaria; Ronald M Fairman; Nimesh D Desai; Alberto Pochettino; Wilson Y Szeto Journal: J Thorac Cardiovasc Surg Date: 2010-12 Impact factor: 5.209
Authors: Christoph A Nienaber; Stephan Kische; Hervé Rousseau; Holger Eggebrecht; Tim C Rehders; Guenther Kundt; Aenne Glass; Dierk Scheinert; Martin Czerny; Tilo Kleinfeldt; Burkhart Zipfel; Louis Labrousse; Rossella Fattori; Hüseyin Ince Journal: Circ Cardiovasc Interv Date: 2013-08-06 Impact factor: 6.546
Authors: Jennifer M Hanna; Nicholas D Andersen; Asvin M Ganapathi; Richard L McCann; G Chad Hughes Journal: J Vasc Surg Date: 2013-10-01 Impact factor: 4.268
Authors: I Chemelli-Steingruber; A Chemelli; A Strasak; B Hugl; R Hiemetzberger; W Jaschke; B Glodny; B V Czermak Journal: Eur J Radiol Date: 2008-11-08 Impact factor: 3.528
Authors: Julio A Rodriguez; Dawn M Olsen; Leonardo Lucas; Grayson Wheatley; Venkatesh Ramaiah; Edward B Diethrich Journal: J Vasc Surg Date: 2008-04-28 Impact factor: 4.268
Authors: Maximilian Kreibich; Bartosz Rylski; Stoyan Kondov; Julia Morlock; Johannes Scheumann; Fabian A Kari; Holger Schröfel; Matthias Siepe; Friedhelm Beyersdorf; Martin Czerny Journal: J Vis Surg Date: 2018-04-04
Authors: Eric Y Pruitt; Salvatore T Scali; Dean J Arnaoutakis; Martin R Back; George J Arnaoutakis; Tomas D Martin; Thomas M Beaver; Thomas S Huber; Gilbert R Upchurch Journal: J Cardiovasc Surg (Torino) Date: 2020-09-23 Impact factor: 1.888
Authors: María Elena Arnáiz-García; José María González-Santos; Ana María Arnáiz-García; Javier Arnáiz Journal: J Thorac Dis Date: 2017-10 Impact factor: 2.895
Authors: Kristina A Giles; Adam W Beck; Salim Lala; Suzannah Patterson; Martin Back; Javairiah Fatima; Dean J Arnaoutakis; George J Arnaoutakis; Thomas M Beaver; Scott A Berceli; Gilbert R Upchurch; Thomas S Huber; Salvatore T Scali Journal: J Vasc Surg Date: 2018-12-13 Impact factor: 4.268